Hu Yang
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 36
- Advanced biosensing and bioanalysis techniques 13
-
- Dendrimers and Hyperbranched Polymers 43
- Co-authors
- Juan Wang (23 shared papers)Stephanie T. Lopina (6 shared papers)Remy C. Cooper (11 shared papers)W. Andrew Yeudall (15 shared papers)Weiyuan John Kao (4 shared papers)Quan Yuan (12 shared papers)Boxuan Li (11 shared papers)Donald C. Aduba (5 shared papers)
- Journals
- Biomacromolecules (9 papers)Journal of Controlled Release (7 papers)Journal of Biomedical Materials Research Part A (5 papers)Acta Biomaterialia (4 papers)Molecular Pharmaceutics (4 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Hu Yang
132 papers receiving 4.8k citations
Hu Yang's Hit Papers
Peers
Comparison fields: 5 of 141
- Biomaterials 1.4k
- Pharmaceutical Science 561
- Polymers and Plastics 1.0k
- Molecular Medicine 348
- Rehabilitation 180
Countries citing papers authored by Hu Yang
This map shows the geographic impact of Hu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Yang more than expected).
Fields of papers citing papers by Hu Yang
This network shows the impact of papers produced by Hu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Yang. The network helps show where Hu Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hu Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dendrimer-based drug delivery systems: history, challenges, and latest developments Hit paper breakdown → | 2022 | 246 |
| 2 | 2012 | 163 | |
| 3 | 2017 | 159 | |
| 4 | 2010 | 157 | |
| 5 | 2004 | 154 | |
| 6 | 2019 | 139 | |
| 7 | 2018 | 132 | |
| 8 | 2018 | 129 | |
| 9 | 2005 | 128 | |
| 10 | 2003 | 107 | |
| 11 | 2011 | 103 | |
| 12 | 2017 | 96 | |
| 13 | 2020 | 89 | |
| 14 | 2013 | 81 | |
| 15 | 2011 | 79 | |
| 16 | 2017 | 76 | |
| 17 | 2010 | 75 | |
| 18 | 2013 | 73 | |
| 19 | 2017 | 68 | |
| 20 | 2022 | 68 |
About Hu Yang
Hu Yang is a scholar working on Molecular Biology, Polymers and Plastics, Biomaterials, Organic Chemistry and Biomedical Engineering, having authored 138 papers that have together received 4.9k indexed citations. Recurring topics across this work include Dendrimers and Hyperbranched Polymers (43 papers), RNA Interference and Gene Delivery (36 papers), Advanced biosensing and bioanalysis techniques (13 papers), Electrospun Nanofibers in Biomedical Applications (12 papers), Advanced Polymer Synthesis and Characterization (11 papers), Nanoparticle-Based Drug Delivery (11 papers), Nanoplatforms for cancer theranostics (9 papers) and Proteoglycans and glycosaminoglycans research (8 papers). The work is most often cited by research in Biomaterials (1.4k citations), Pharmaceutical Science (561 citations), Polymers and Plastics (1.0k citations), Molecular Medicine (348 citations) and Rehabilitation (180 citations). Hu Yang has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Juan Wang, Stephanie T. Lopina, Remy C. Cooper, W. Andrew Yeudall, Weiyuan John Kao, Quan Yuan, Boxuan Li, Donald C. Aduba, Hongliang He and Leyuan Xu. Their work appears in journals such as Biomacromolecules, Journal of Controlled Release, Journal of Biomedical Materials Research Part A, Acta Biomaterialia and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.